Your browser doesn't support javascript.
loading
A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association.
Huang, Huachao; Liu, Shuai; Jean, Maxime; Simpson, Sydney; Huang, He; Merkley, Mark; Hayashi, Tsuyoshi; Kong, Weili; Rodríguez-Sánchez, Irene; Zhang, Xiaofeng; Yosief, Hailemichael O; Miao, Hongyu; Que, Jianwen; Kobie, James J; Bradner, James; Santoso, Netty G; Zhang, Wei; Zhu, Jian.
Afiliación
  • Huang H; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Liu S; Department of Chemistry, University of Massachusetts BostonBoston, MA, United States.
  • Jean M; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Simpson S; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Huang H; Department of Chemistry, Laufer Center for Physical and Quantitative Biology, Stony Brook UniversityStony Brook, NY, United States.
  • Merkley M; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Hayashi T; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Kong W; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Rodríguez-Sánchez I; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Zhang X; Department of Chemistry, University of Massachusetts BostonBoston, MA, United States.
  • Yosief HO; Department of Chemistry, University of Massachusetts BostonBoston, MA, United States.
  • Miao H; Department of Biostatistics, School of Public Health, University of Texas Health Science CenterHouston, TX, United States.
  • Que J; Department of Medicine, Columbia University Medical CenterNew York, NY, United States.
  • Kobie JJ; Department of Medicine, University of Rochester Medical CenterRochester, NY, United States.
  • Bradner J; Harvard Medical School, Dana-Farber Cancer InstituteBoston, MA, United States.
  • Santoso NG; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
  • Zhang W; Department of Chemistry, University of Massachusetts BostonBoston, MA, United States.
  • Zhu J; Department of Microbiology and Immunology, University of Rochester Medical CenterRochester, NY, United States.
Front Microbiol ; 8: 1035, 2017.
Article en En | MEDLINE | ID: mdl-28638377
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Microbiol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Microbiol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos